Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma

被引:0
作者
Nguyen, PL [1 ]
Zukerberg, LR [1 ]
Benedict, WF [1 ]
Harris, NL [1 ]
机构
[1] BAYLOR COLL MED,CTR BIOTECHNOL,THE WOODLANDS,TX 77381
关键词
p53; bcl-2; retinoblastoma protein; apoptosis; programmed cell death; cell cycle; lymphoma; follicle center; cytologic grade;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mutations of p53 have been suggested to be involved in the histologic transformation of follicular lymphoma, but the role of the retinoblastoma (RE) gene, another tumor suppressor gene, in lymphomagenesis has not been established. To determine the roles of these tumor suppressor genes and their relationship with the anti-apoptotic bcl-2 gene in follicle center lymphoma, the immunohistochemical expression of p53, bcl-2, and RE proteins was correlated with cytologic grade in 50 cases of follicular lymphoma, and the results were compared to 23 cases of diffuse large B-cell lymphoma. The results showed that only 2 of 25 grade 1 follicular lymphoma were p53-positive compared to 16 of 25 grade 3 cases (P <.0001). A significantly lower number (13 of 25) of grade 3 follicular lymphomas expressed bcl-2 compared to grade 1 cases (23 of 25) (P <.004). Eight of 14 bcl-2-negative follicular lymphomas expressed p53, compared with 10 of 36 bcl-2-positive cases (P = .1). Twenty-four of 25 grade 3 follicular lymphomas showed 2+ to 3+ staining for RE protein compared to 9 of 21 grade 1 cases (P <.0002). Expression of p53 protein correlates significantly with higher cytologic grade in follicular lymphoma, Similar to earlier studies of breast cancer and lymphoma, there appears to be an inverse relationship between p53 and bcl-2 expression in follicular lymphoma, Inactivation of the retinoblastoma gene does not seem to be involved in the histogenesis of follicle center lymphoma or diffuse large B-cell lymphoma.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 50 条
  • [41] Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma
    Halasova, E.
    Adamkov, M.
    Matakova, T.
    Vybohova, D.
    Antosova, M.
    Janickova, M.
    Singliar, A.
    Dobrota, D.
    Jakusova, V.
    RESPIRATORY REGULATION - THE MOLECULAR APPROACH, 2013, 756 : 15 - 21
  • [42] Expression of BCL-2 and p53 in oncocytic (Hurthle cell) tumors of the thyroid: An immunohistochemical study
    Kohli, A
    Baker, SP
    Patwardhan, NA
    Khan, A
    ENDOCRINE PATHOLOGY, 1998, 9 (02) : 117 - 123
  • [43] Expression of Bcl-2 in lung neuroendocrine tumours: Comparison with p53
    Wang, DG
    Johnston, CF
    Sloan, JM
    Buchanan, KD
    JOURNAL OF PATHOLOGY, 1998, 184 (03) : 247 - 251
  • [44] Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas
    Ilyas, M
    Kendall, M
    Jalal, H
    Linton, C
    Rooney, N
    JOURNAL OF PATHOLOGY, 1996, 180 (03) : 249 - 253
  • [45] Immunohistochemical investigation of bcl-2 and p53 levels in rat hypothalamus after sleep deprivation
    I. V. Artamokhina
    V. A. Belova
    I. V. Romanova
    Journal of Evolutionary Biochemistry and Physiology, 2011, 47 : 458 - 463
  • [46] The tissue dependent interactions between p53 and Bcl-2 in vivo
    Li, Xin
    Miao, Xiao
    Wang, Hongshen
    Xu, Zhixiang
    Li, Bin
    ONCOTARGET, 2015, 6 (34) : 35699 - 35709
  • [47] Negative regulation of bcl-2 expression by p53 in hematopoietic cells
    Wu, YL
    Mehew, JW
    Heckman, CA
    Arcinas, M
    Boxer, LM
    ONCOGENE, 2001, 20 (02) : 240 - 251
  • [48] Expression of Bax, Bcl-2, and p53 in progressive multifocal leukoencephalopathy
    Yang, B
    Prayson, RA
    MODERN PATHOLOGY, 2000, 13 (10) : 1115 - 1120
  • [49] Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression
    Moore, D
    Ohene-Fianko, D
    Garcia, B
    Chakrabarti, S
    HISTOPATHOLOGY, 1998, 32 (01) : 35 - 42
  • [50] Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia
    Kyokane, K
    Ito, M
    Sato, Y
    Ina, K
    Ando, T
    Kusugami, K
    JOURNAL OF PATHOLOGY, 1998, 184 (04) : 382 - 389